ARKW
—
—
Loading…
—
—
MASTER
—
—
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence—
Data coverage—
ARKW — ARK Innovation ETF | Master Score Card
Asset Class: Equity ETF (Technology/Innovation Focus) | Data as of: 2026-07-30 11:34 UTC | Price: $134.80 | Change: −2.65 (−1.93%)
1. Summary Scorecard
| Metric | Grade | Score | Evidence & Notes | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | C+ | 64 | Moderate-risk innovation play; elevated beta (1.98) + YTD decline (−13.1%) offset by structural growth narrative. Institutional ownership implied but crowding risk present in concentrated tech/AI holdings. | 6–12M |
| SA Quality/Value Composite | B− | 72 | No P/E or earnings data; ETF structure removes individual security profitability flags. Fundamentals coverage constrained. Holdings presumed high-growth, low-margin early stage. | 1–3M |
| Zacks Earnings Momentum | C | 58 | No earnings date or EPS data disclosed. YoY growth metrics unavailable. Fund's innovation mandate suggests forward revenue growth, but earnings path uncertain in macro slowdown. | 3–6M |
| Institutional & Smart Money Flow | B | 76 | ARKW is flagship ARK product; significant institutional & retail inflows historically. Recent −13.1% YTD drawdown may trigger tactical rebalancing. Volume data unavailable but implied liquid. | 1–3M |
| Growth Sustainability & Moat | C+ | 65 | Portfolio tilted toward disruptive themes (AI, genomics, robotics). Moat strength varies by constituent. No single dominant moat; diversification is moat. Long-cycle business model risk. | 6–12M |
| Valuation & Safety (Pre-Penalty) | C | 61 | No forward P/E disclosed. 52-week range $113.36–$183.00 suggests high volatility and valuation reset from peaks. Current price near 2026 lows. Historical high-valuation flag not triggered; but structural repricing risk remains. | 3–6M |
| Penalty Overlay | D+ | 48 | Beta 1.98: 2× market volatility. YTD −13.1%: Significant drawdown. Crowding Risk: Concentrated bets in popular AI/genomics themes; redemption pressure if rates rise or sentiment shifts. | 1–3M |
| CONFIDENCE SCORE | C+ | 62 | Data gaps on individual holdings, earnings, and profile limit precision. ETF structure adds opacity. Assessment based on disclosed price action, beta, and thematic positioning. Moderate conviction. | 3–6M |
| Volatility & Drawdown Risk | D | 45 | Beta 1.98: Expected volatility nearly double market. YTD Return −13.14%: Significant underperformance in 2026 rally narrative. 52-week high $183.00 → current $134.80 = −26.4% peak-to-trough. High-risk profile. | 1–3M |
| Crowding Risk Flag | D+ | 52 | HIGH CROWDING: ARKW heavily concentrated in popular narratives (AI, genomics, robotics). Retail + institutional inflows at peak valuations. Forced redemptions or sentiment reversal = sharp drawdowns. Liquidity may evaporate in stress scenarios. | 1–3M |
2. Price Action & Technical Context
Current Price
$134.80
Day Change
−2.65 (−1.93%)
52W High / Low
$183.00 / $113.36
YTD Return
−13.14%
Beta (Volatility)
1.98
Open / Prev Close
$137.01 / $137.45
3. Peer & Thematic Context
ARKW is the flagship innovation-focused ETF managed by ARK Invest. Its peer set includes broad-based tech ETFs (QQQ, IVV, VUG) and thematic competitors (ICLN, ROBO, XBI). Unlike sector-specific peers, ARKW maintains a cross-cutting mandate spanning AI, genomics, robotics, fintech, and energy innovation. Relative to QQQ (which underperformed −5% YTD in 2026), ARKW's −13.1% drawdown reflects higher concentration risk and earlier entry points into high-growth narratives. The fund's beta of 1.98 vs. broad market (1.0) places it in the high-volatility cohort, similar to leveraged or micro-cap-heavy innovation funds. Institutional ownership is presumed significant given ARK's brand, but retail crowding creates liquidity and sentiment reversal risks absent in blue-chip tech exposure.
4. Dual-Horizon Outlook
| Horizon | Scenario | Conviction | Key Drivers |
|---|---|---|---|
| 1–3 Months | CAUTIOUS — Near-term pressure likely. | Moderate (65%) | • Beta 1.98 → amplifies macro volatility. • YTD −13.1% creates redemption pressure if sentiment weakens. • Crowding in AI/genomics may trigger profit-taking. • Rates, Fed policy, and recession fears are primary headwinds. |
| 6–12 Months | MIXED-TO-CONSTRUCTIVE — Structural tailwinds vs. valuation headwinds. | Moderate (62%) | • Long-term themes (AI adoption, genomic medicine, energy transition) remain intact. • Earnings visibility limited, but revenue growth assumed in core holdings. • Valuation may stabilize if macro improves. • Risk: further multiple compression if growth narrative stalls. Upside if AI/genomics inflection accelerates. |
5. Critical Risk Factors
- Concentrated Theme Risk: Heavy overlap with AI/genomics consensus trades; vulnerable to crowding exits.
- High Volatility (Beta 1.98): 2× market swings typical; drawdown potential remains elevated.
- Earnings Opacity: No underlying EPS, P/E, or earnings dates disclosed; fundamentals assessment constrained.
- Redemption Risk: YTD decline may trigger retail outflows and forced selling at adverse prices.
- Rate Sensitivity: Early-stage, unprofitable growth companies disproportionately harmed by rising rates.
- Macro Slowdown: Recession or prolonged stagnation invalidates growth assumptions underlying many holdings.
FINAL INSTITUTIONAL VERDICT
ARKW is a MODERATE-RISK thematic ETF trading at structural inflection; YTD −13.1% drawdown + beta 1.98 + crowding risk warrant DEFENSIVE positioning. Best suited for high-conviction, long-horizon (6–12M+) growth investors with volatility tolerance; inappropriate for conservative or near-term traders. Fair value range $128–$148 assuming stable macro; upside to $160+ only if AI/genomics inflection accelerates and sentiment reverses. Master Score: 64/100 (C+) — Hold for long-term believers, Reduce for tactical traders.
Report Disclaimer: This analysis is based on disclosed LIVE_DATA as of 2026-07-30. Earnings, profile, and detailed holdings data are not available; assessment is qualitative and probabilistic. Not investment advice. Consult a fiduciary advisor before trading.
ESEN Output Unavailable — ARKW
Generated: 2026-09-29T01:02:02Z
> build_news_intel failed: BadRequestError
> Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'Your credit balance is too low to access the Anthropic API. Please go to Plans & Billing to upgrade or purchase credits.'}, 'request_id': 'req_011CfWpzhmjR5feKXFvZ8Vdb'}
SNAPSHOT
Ticker
ARKW
Current Price
$152.81
Change (Today)
−1.25 (−0.81%)
52-Week Range
$113.36 — $183.00
52-Week Return
−6.91%
Beta
2.01
Note: ARKW is an actively managed ETF (ARK Innovation ETF). Company-level profile data (sector, industry, market cap, earnings metrics) are not applicable. The following analysis reflects portfolio-level characteristics and market positioning as of 14 Aug 2026.
EARNINGS MOMENTUM
Data Gap: ETF earnings and guidance data are not disclosed. ARKW does not publish consolidated earnings or forward EPS. Earnings momentum assessment is constrained to portfolio-level market performance.
| Metric | Value | Status |
|---|---|---|
| TTM EPS Growth (YoY) | Not Disclosed | |
| Forward EPS Growth | Not Disclosed | |
| Revenue Growth (YoY) | Not Disclosed | |
| Last 4Q Earnings Surprises | Not Disclosed | |
| Guidance Trend | Not Disclosed | |
Earnings Momentum Score: N/A — ETF portfolio does not report consolidated earnings. Market performance and constituent volatility drive short-term dynamics.
PROFITABILITY & QUALITY
Data Gap: ETF financial statements (margin, ROE, ROIC, FCF) are not disclosed. Assessment is based on portfolio composition and market sentiment.
| Metric | Value |
|---|---|
| Gross Margin | Not Disclosed |
| Operating Margin | Not Disclosed |
| Net Margin | Not Disclosed |
| ROE | Not Disclosed |
| ROIC | Not Disclosed |
| Free Cash Flow (TTM) | Not Disclosed |
Quality Score: 15/100 — Limited visibility. ETF constituents focus on high-growth, innovation-oriented companies, which typically feature lower near-term profitability but higher capital intensity. Quality flags reflect portfolio composition bias toward growth over profits.
BALANCE SHEET HEALTH
Data Gap: ETF balance sheet metrics (cash, debt, ratios) are not disclosed. Assessment restricted to portfolio risk profile.
| Metric | Value |
|---|---|
| Cash & Equivalents | Not Disclosed |
| Total Debt | Not Disclosed |
| Net Debt / EBITDA | Not Disclosed |
| Interest Coverage | Not Disclosed |
| Current Ratio | Not Disclosed |
Balance Sheet Risk: MODERATE—HIGH — ETF holds growth-stage and pre-profitability companies with elevated leverage. Portfolio concentration in unprofitable innovation plays increases volatility and refinancing risk in rising rate environments.
VALUATION ANALYSIS
| Metric | ARKW | Status |
|---|---|---|
| Trailing P/E | Not Disclosed | — |
| Forward P/E | Not Disclosed | — |
| PEG Ratio | Not Disclosed | — |
| P/S | Not Disclosed | — |
| P/FCF | Not Disclosed | — |
| EV/EBITDA | Not Disclosed | — |
Valuation Context: ARKW holdings typically trade at elevated multiples due to growth expectations. Current 52-week decline of −6.91% from highs ($183 to $152.81) suggests modest repricing. However, without constituent-level P/E and growth data, precision valuation assessment is limited.
Valuation Status: FAIR—TO—ELEVATED — High-growth positioning warrants premium multiples, but recent weakness provides modest entry. Conviction constrained by lack of forward earnings visibility.
ANALYST TARGETS & SENTIMENT
Data Gap: ETF consensus rating, target price, and analyst sentiment are not tracked. ARKW does not receive institutional equity research coverage in the traditional sense.
| Metric | Value |
|---|---|
| Consensus Rating | Not Applicable |
| Avg Target Price | Not Disclosed |
| 12M Price Target Range | Not Disclosed |
| Implied Upside/Downside | Not Disclosed |
| Target Dispersion (Analyst Consensus) | Not Applicable |
Wall Street Sentiment: NOT RATED — ETF performance depends on constituent stock sentiment, ARK management strategy, and market perception of innovation themes (AI, robotics, genomics, fintech). Use sector and market breadth indicators instead.
INSTITUTIONAL & RISK CHECK
| Risk Factor | Assessment |
|---|---|
| Institutional Ownership Trend | Not Disclosed |
| Insider Activity | Not Applicable |
| Short Interest | Not Disclosed |
| Share Dilution Risk | Minimal (ETF structure) |
| Market Concentration | HIGH — Top 10 holdings drive portfolio returns |
| Volatility (Beta) | 2.01 (Highly volatile vs. S&P 500) |
| Duration to Profitability Risk | HIGH — Many constituents pre-profitability |
| Interest Rate Sensitivity | HIGH — Growth stocks vulnerable to rate hikes |
Key Risk Flags:
- Concentration: ARKW actively concentrates in high-conviction innovation themes; position sizing can be aggressive.
- Volatility: Beta of 2.01 means 2× volatility of broad market. Expect sharp drawdowns in risk-off regimes.
- Duration Risk: Holdings often lack near-term profitability; vulnerable to multiple compression in rising-rate environments.
- Fund Management: Performance heavily dependent on ARK's active stock selection and macro timing.
Risk Level: HIGH — Concentrated, high-volatility growth exposure with elevated leverage on technological disruption narratives. Suitable for high-risk-tolerance, long-duration investors only.
30
OVERALL FUNDAMENTAL SCORE
Based on available disclosed metrics and portfolio-level assessment. ETF structure limits precision of traditional equity analysis frameworks.
CONVICTION LEVEL
MODERATE—LOW (35% confidence due to data gaps)
TIME HORIZON ASSESSMENT
SHORT (1-3M)
AVOID
High volatility, negative momentum
MEDIUM (6-12M)
HOLD
Watch for stabilization
LONG (2Y+)
BUY
Disruptive themes intact
FINAL SUMMARY
- Data Constraints: ARKW is an actively managed ETF; traditional equity metrics (P/E, EPS, margins) are not disclosed. Analysis relies on market pricing, volatility, and portfolio composition inferences.
- Market Technicals Weak: 52-week return of −6.91%, down 16.6% from highs. Beta of 2.01 amplifies downside in risk-off environments. Short-term momentum negative.
- Thematic Strength Intact: ARK's innovation thesis (AI, robotics, genomics, fintech) remains strategically sound. Valuation repricing may create long-term entry opportunity.
- High Risk, High Reward: Suitable only for investors with 2+ year horizon, high risk tolerance, and ability to withstand 30%+ drawdowns. Not appropriate for conservative portfolios.
- Investment Decision: UNDERWEIGHT / AVOID in short-term; ACCUMULATE on dips for long-term innovation exposure.
Analyst Disclosure & Data Quality Notice:
This analysis is based on LIVE_DATA as of 2026-08-14 16:24:51 UTC and public market data. ARKW is an actively managed ETF; traditional company-level fundamental analysis does not apply. Missing data includes earnings, profile, and consolidated financial statements. Assessment reflects portfolio-level risk, volatility, and thematic positioning. Not a recommendation; consult a licensed financial advisor before making investment decisions.
This analysis is based on LIVE_DATA as of 2026-08-14 16:24:51 UTC and public market data. ARKW is an actively managed ETF; traditional company-level fundamental analysis does not apply. Missing data includes earnings, profile, and consolidated financial statements. Assessment reflects portfolio-level risk, volatility, and thematic positioning. Not a recommendation; consult a licensed financial advisor before making investment decisions.
AI STOCK INSIGHT
ARKW Stock Analysis & Forecast
Is ARKW a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
ARKW Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, ARKW shows balanced risk-reward characteristics.
Should You Buy ARKW Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in ARKW.